文献速递主动脉疾病

EVAR术后阿片类药物处方与消耗习惯评估

Evaluation of Opioid Prescription and Consumption Habits Following Endovascular Aortic Aneurysm Repair.
PubMed 文献 · Ann Vasc Surg · 2021-02-04

42%获处方,仅约18%药片被消耗,82%未使用;年龄、术中失血量及住院每日OME为处方预测因素。

要点

  • EVAR术后42%患者出院获阿片处方,但82%处方药片未被消耗。
  • 住院阿片用量、年龄及术中失血量可预测出院阿片处方需求。
  • 开放股动脉入路并非出院阿片处方的预测因素。

核心结论

  • EVAR术后患者实际消耗的阿片类药物远少于处方量,82%的处方药片未被使用。
  • 年龄、术中失血量及住院每日口服吗啡当量为出院阿片处方的住院预测因素。

研究设计与样本

  • 对出院获阿片处方的患者进行用药调查,应答率59%。

主要发现

  • 71例(42%)出院时获阿片处方;获处方者更年轻(71 vs. 75岁,P=0.005),住院阿片使用比例更高(79% vs. 45%,P<0.001)。
  • 获处方者住院期间口服吗啡当量显著更高(27.76 ± 38.91 vs. 10.05 ± 29.43,P<0.001)。
  • 共处方1185片(每患者29.6 ± 2.06片),仅消耗208片(每患者5.2 ± 1.27片),约82%未消耗。
  • 开放股动脉入路(27%)不是出院阿片处方的预测因素。

临床怎么用

  • EVAR术后可考虑减少常规阿片处方量,尤其对年轻、住院阿片用量低及失血量少的患者。

局限性

  • 调查应答率59%,可能存在无应答偏倚。
  • 样本以白人(95%)和男性(85%)为主,外推性受限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There has been a dramatic rise in opioid-related deaths over the past decade. Most of the reduction strategies have focused on outpatient use; however, recent studies have demonstrated an association between inpatient opioid use and consumption following discharge across a variety of surgical procedures. The objective of this study is to evaluate the association of inpatient use of opioids as well as the consumption of opioids after discharge following endovascular aortic aneurysm repair (EVAR). METHODS: A prospectively maintained database was reviewed for cases between 2015 and 2018. Patients were included in the study if they underwent an elective EVAR, had an intensive care unit stay less than 1 day and total length of stay less than 3 days. Patients were contacted to participate in a survey of opioid use if they received a prescription at discharge. The primary outcome was percent of prescribed opioids consumed following discharge. Multivariate analyses were performed to determine predictors of receiving an opioid prescription. RESULTS: One hundred seventy-one patients were included in the analysis; 95% patients were white and 85% male. 59% of patients responded to the survey. Seventy-one (42%) received an opioid prescription at discharge. Patients that received a discharge prescription tended to be younger (71 vs. 75 years, P = 0.005) and more likely to have received opioids while in the hospital (79% vs. 45%, P < 0.001). Additionally, patients who received opioids at discharge received a significantly greater amount of milligram oral morphine equivalents (OME) while in the hospital (27.76 ± 38.91 vs. 10.05 ±29.43, P < 0.001). Multivariate analysis demonstrated age, estimated blood loss (EBL), and OME per day to be significant inpatient predictors of requiring an outpatient opioid prescription. Open femoral access (27%) was not a predictor of opioid prescription at discharge. A total of 1185 pills were prescribed (29.6 ± 2.06 per patient), but only 208 pills consumed (5.2 ± 1.27 per patient). Around 82% of total pills prescribed were not consumed. CONCLUSIONS: This study evaluates inpatient opioid use and postdischarge consumption following EVAR. These data identify key factors associated with receiving an opioid prescription at discharge and demonstrate that patients consume far fewer opioids than prescribed. These findings provide insight as to which patients may not require an outpatient prescription following EVAR, leading to potential practice-changing opioid reduction strategies.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Balceniuk MD, Blegen MB, Ayers BC, et al. Evaluation of Opioid Prescription and Consumption Habits Following Endovascular Aortic Aneurysm Repair. Ann Vasc Surg. 2021. PMID: 33548403. doi:10.1016/j.avsg.2020.12.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。